Home600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Previous close
¥3.64
Day range
¥3.63 - ¥3.66
Year range
¥3.06 - ¥4.97
Market cap
9.19B CNY
Avg Volume
27.23M
P/E ratio
20.47
Dividend yield
-
Primary exchange
SHA
Market news
BNN Bloomberg
1 day ago
Central bank commentary weighs on risk assets, following BoC and Fed rate cuts
0.11%
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.90B | -5.29% |
Operating expense | 838.57M | 2.13% |
Net income | 68.89M | -58.22% |
Net profit margin | 1.77 | -55.86% |
Earnings per share | — | — |
EBITDA | 166.37M | -50.19% |
Effective tax rate | 34.67% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.74B | -12.32% |
Total assets | 14.08B | -1.31% |
Total liabilities | 7.67B | -7.75% |
Total equity | 6.41B | — |
Shares outstanding | 2.52B | — |
Price to book | 1.62 | — |
Return on assets | 2.00% | — |
Return on capital | 3.67% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 68.89M | -58.22% |
Cash from operations | -192.48M | -283.26% |
Cash from investing | -54.77M | -55.00% |
Cash from financing | -88.11M | 49.20% |
Net change in cash | -334.93M | -222.01% |
Free cash flow | -402.50M | -471.06% |
About
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Founded
1988
Website
Employees
10,180
